← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Fannin Partners, Llc
Houston, TX
$10,167,978
Total funding
15
Grants
Funding over time
peak $2.3M · FY2017–25$2.5M$1.9M$1.3M$625K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,968,006 · 14
FDA$199,972 · 1
By mechanism
R44$7,176,501 · 4
R43$2,991,477 · 11
Investigators at Fannin Partners, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Early clinical development of a novel IL-7R antibody for treating children with relapsed T-cell leukemia$999,997
R44 · FY2022 · CA
Early clinical development of a novel IL-7R antibody for treating children with relapsed T-cell leukemia$999,997
R44 · FY2025 · CA
Preclinical evaluation of a novel small molecule STAT inhibitor$999,993
R44 · FY2018 · AI
Uterine Wall-Membrane Anchor Device for the Prevention of Preterm Premature Rupture of the Membranes Following Fetoscopic Surgery$998,650
R44 · FY2019 · HD
Aptamer therapeutic for safe and low-cost treatment of snake bite envenomation$993,974
R44 · FY2021 · OD
Uterine Wall-Membrane Anchor Device for the Prevention of Preterm Premature Rupture of the Membranes Following Fetoscopic Surgery$981,505
R44 · FY2020 · HD
Aptamer therapeutic for safe and low-cost treatment of snake bite envenomation$978,343
R44 · FY2022 · OD
Novel inhibitor of PDE4 for the treatment of opioid use disorder$349,867
R43 · FY2020 · DA
Reconstituted High Density Lipoprotein Particles as siRNA Carriers$324,593
R43 · FY2017 · TR
Investigation of a Novel PDE4B Inhibitor for Stimulant Use Disorder$320,000
R43 · FY2024 · DA
Developing Scg3 Raptamers as a novel targeted therapy for wet AMD$300,016
R43 · FY2025 · EY
Expediting the Biomarker Discovery Process Through a Novel Bead-Based Aptamer Capture Platform$299,921
R43 · FY2022 · GM
Novel Small Molecule Targeting STAT Proteins for the Management of Atopic Dermatitis$243,014
R43 · FY2017 · AI
Innovative Delivery of siRNA across the Blood Brain Barrier$224,989
R43 · FY2018 · AG
Artificial Urethral Sphincter for Control of Urinary Incontinence in Pediatric Patients$224,771
R43 · FY2019 · DK
Ureteral Stent Electromagnetic Removal (USER) Device for Pediatric Patients$224,692
R43 · FY2017 · DK
Uterine Wall-Membrane Anchor Device for the Prevention of Preterm Premature Rupture of the Membranes Following Fetoscopic Surgery$224,642
R43 · FY2017 · HD
Bedside right-heart catheterization for early diagnosis and more effective management of patients with heart failure and primary pulmonary hypertension$199,972
R43 · FY2023 · FD
Uterine Wall-Membrane Anchor Device for the Prevention of Preterm Premature Rupture of the Membranes Following Fetoscopic Surgery$139,727
R44 · FY2021 · HD
Early clinical development of a novel IL-7R antibody for treating children with relapsed T-cell leukemia$84,315
R44 · FY2023 · CA